We showed that the candidate biomarkers were associated with the diagnosis, therapy, or prognosis of human cancers, including colon cancer, in which provided further evidence for the CHGA as a potential hub biomarker for the colon cancer. This evidence concerns the gene CHGA and malignant colon neoplasm.